Fennec Pharmaceuticals (FENC) Enterprise Value (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -67.62% |
| Sep 30, 2025 | -17.33% |
| Jun 30, 2025 | 17.51% |
| Mar 31, 2025 | 14.86% |
| Dec 31, 2024 | 33.94% |
| Sep 30, 2024 | 6.35% |
| Jun 30, 2024 | 15.88% |
| Mar 31, 2024 | -285.74% |
| Dec 31, 2023 | -7.02% |
| Sep 30, 2023 | 17.11% |
| Jun 30, 2023 | -12.73% |
| Mar 31, 2023 | 44.19% |
| Dec 31, 2022 | 20.09% |
| Sep 30, 2022 | -99.48% |
| Jun 30, 2022 | 18.31% |
| Mar 31, 2022 | 13.46% |
| Dec 31, 2021 | 13.29% |
| Sep 30, 2021 | 10.84% |
| Jun 30, 2021 | -2.03% |
| Mar 31, 2021 | 11.84% |
| Dec 31, 2020 | 8.51% |
| Sep 30, 2020 | 14.36% |
| Jun 30, 2020 | -291.16% |
| Mar 31, 2020 | 27.47% |
| Dec 31, 2019 | 10.43% |
| Sep 30, 2019 | -11.65% |
| Jun 30, 2019 | 32.53% |
| Mar 31, 2019 | 11.19% |
| Dec 31, 2018 | 7.11% |
| Sep 30, 2018 | 4.35% |
| Jun 30, 2018 | 4.04% |
| Mar 31, 2018 | 5.45% |
| Dec 31, 2017 | -191.70% |
| Sep 30, 2017 | 5.32% |
| Jun 30, 2017 | -214.73% |
| Mar 31, 2017 | 17.19% |
| Dec 31, 2016 | 13.47% |
| Sep 30, 2016 | 10.71% |
| Jun 30, 2016 | -832.29% |
| Mar 31, 2016 | 42.14% |
| Dec 31, 2015 | 31.04% |
| Sep 30, 2015 | 26.32% |
| Jun 30, 2015 | 3.24% |
| Mar 31, 2015 | 16.95% |
| Dec 31, 2014 | -289.04% |
| Sep 30, 2014 | 41.58% |
| Jun 30, 2014 | 24.14% |
| Mar 31, 2014 | 19.54% |
| Dec 31, 2013 | -209.11% |
| Sep 30, 2013 | 46.57% |
| Jun 30, 2013 | 46.89% |
| Mar 31, 2013 | 17.67% |
| Dec 31, 2012 | 19.48% |
| Sep 30, 2012 | 20.25% |
| Jun 30, 2012 | 24.01% |
| Mar 31, 2012 | 10.91% |
| Dec 31, 2011 | 14.20% |
| Sep 30, 2011 | 9.34% |
| Jun 30, 2011 | -35.58% |
| Mar 31, 2011 | 15.54% |
| Dec 31, 2010 | 9.92% |
| Sep 30, 2010 | 7.69% |